Journalartikel
Autorenliste: Klimek, Ludger; Brehler, Randolf; Hamelmann, Eckard; Kopp, Matthias; Ring, Johannes; Treudler, Regina; Jakob, Thilo; Worm, Margitta; Pfaar, Oliver
Jahr der Veröffentlichung: 2019
Seiten: 26-46
Zeitschrift: Allergo-Journal
Bandnummer: 28
Heftnummer: 3
ISSN: 0941-8849
eISSN: 2195-6405
Open Access Status: Hybrid
DOI Link: https://doi.org/10.1007/s40629-019-0092-4
Verlag: SPRINGER HEIDELBERG
Zitierstile
Harvard-Zitierstil: Klimek, L., Brehler, R., Hamelmann, E., Kopp, M., Ring, J., Treudler, R., et al. (2019) Evolution of subcutaneous Allergen Immunotherapy (Part 1): From first Developments to immunologically oriented Therapy Concepts, Allergo-Journal, 28(3), pp. 26-46. https://doi.org/10.1007/s40629-019-0092-4
APA-Zitierstil: Klimek, L., Brehler, R., Hamelmann, E., Kopp, M., Ring, J., Treudler, R., Jakob, T., Worm, M., & Pfaar, O. (2019). Evolution of subcutaneous Allergen Immunotherapy (Part 1): From first Developments to immunologically oriented Therapy Concepts. Allergo-Journal. 28(3), 26-46. https://doi.org/10.1007/s40629-019-0092-4
Schlagwörter
CAT-INDUCED ASTHMA; CLINICAL-EFFICACY; DERMATOPHAGOIDES-PTERONYSSINUS; DOUBLE-BLIND TRIAL; GRASS-POLLEN IMMUNOTHERAPY; HOUSE-DUST-MITE; MONOPHOSPHORYL-LIPID-A; PARTIALLY PURIFIED EXTRACT; SHORT-TERM IMMUNOTHERAPY
